Summary:
- This article reports the results of a clinical trial that tested a new treatment for COVID-19 called Paxlovid, which is an antiviral medication.
- The study found that Paxlovid significantly reduced the risk of hospitalization or death in high-risk COVID-19 patients when taken within 5 days of symptom onset.
- The findings suggest that Paxlovid could be an effective tool in the fight against the COVID-19 pandemic, particularly for those at higher risk of severe illness.